Codetta Bio

About:

Codetta Bio is a company developing quantitative & digital spatial platform for nucleic acid & protein assays.

Website: https://codettabio.com/

Top Investors: VC23, Anzu Partners, Genoa Ventures, Bantam Group, Collaboratory

Description:

Codetta Bio is a life sciences company working on a novel multi-omic analysis platform based on digital spatial polymerase chain reaction (dsPCR) and digital spatial immuno polymerase chain reaction (dsIPCR) (dsiPCR). Its integrated reagent, hardware, and software platform enable multiplexed, multi-omic liquid biopsy and isolated DNA, RNA, and protein analyses. The company aims to provide the life sciences community with a simultaneous multi-omic dsPCR solution that will accelerate research and development of next-generation therapies, improving patient care and quality of life.